Gilead rises for the seventh straight session (GILD:NASDAQ)
· seekingalpha.com
Gilead (GILD) stock extends a 7-day rally as HIV sales jump 12% and Q2 revenue beats estimates.
Gilead Sciences (GILD) shares rose 3.4% on Wednesday, extending their winning streak to seven sessions. The stock has gained 11.6% during the streak and was las...